(Q35631580)

9 August 2017

1 reference

title

Review: multidrug-resistant tuberculosis: public health challenges (English)

1 reference

multidrug-resistant tuberculosis

9 August 2017

0 references

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

Richard J Coker

1

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Tropical Medicine and International Health

9 August 2017

published in

1 reference

9 August 2017

volume

9

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

25-40

1 reference

Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Tuberculosis in New York City--turning the tide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Limited transmission of multidrug-resistant tuberculosis despite a high proportion of infectious cases in Los Angeles County, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

The treatment of multidrug-resistant tuberculosis in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Improved outcomes for patients with multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Resource implications of patients with multidrug resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2003.01156.X

10.1046/J.1365-3156.2003.01156.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference